NeuroPro Therapeutics
PrivateLast Round
Early Funding
Mar 1, 2024
Total Funding Raised
$38M
Company Overview
NeuroPro Therapeutics is a biotechnology company that develops proprietary small molecule compounds to treat neurological diseases, including epilepsy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroPro Therapeutics Comparables
Compare NeuroPro Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IAMA Therapeutics | 77% | |
| Ovid Therapeutics Inc. | 77% | |
| EpilepsyGTx | 75% |
NeuroPro Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 1, 2024 | ||||
| Early Funding | Feb 1, 2023 |
NeuroPro Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fengate Asset Management | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 69% MoM, reaching 3.2K.
- Jan 20, 2026
Monthly visitors grew 150% MoM, reaching 1.7K.
NeuroPro Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NeuroPro Therapeutics's valuation, stock price, and market status.
Is NeuroPro Therapeutics a public or private company?
NeuroPro Therapeutics is a private company.
What is the current stock price of NeuroPro Therapeutics?
NeuroPro Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is NeuroPro Therapeutics worth (valuation)?
Valuation information for NeuroPro Therapeutics is not publicly available.
Can I buy NeuroPro Therapeutics stock?
NeuroPro Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NeuroPro Therapeutics's last funding round?
NeuroPro Therapeutics's most recent funding round was Early Funding on March 1, 2024.
Who are the main investors in NeuroPro Therapeutics?
Key investors in NeuroPro Therapeutics include Fengate Asset Management.
Will NeuroPro Therapeutics IPO soon?
No public IPO plans have been announced for NeuroPro Therapeutics.
How can I track NeuroPro Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeuroPro Therapeutics's secondary market activity and sign up for updates.